Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
Rossini F, Terruzzi E, Verga L, Larocca A, Marinoni S, Miccolis I, Giltri G, Isella M, Parma M, Pogliani EM. Rossini F, et al. Among authors: pogliani em. Support Care Cancer. 2005 Jun;13(6):387-92. doi: 10.1007/s00520-004-0753-8. Epub 2004 Dec 15. Support Care Cancer. 2005. PMID: 15599778 Clinical Trial.
Severe, reversible nelarabine-induced neuropathy and myelopathy.
Alberti P, Parma M, Pioltelli P, Pogliani EM, Terruzzi E, Stasia A, Doni E, Cecchetti C, Cavaletti G. Alberti P, et al. Among authors: pogliani em. J Peripher Nerv Syst. 2016 Sep;21(3):154-6. doi: 10.1111/jns.12173. J Peripher Nerv Syst. 2016. PMID: 27117493 No abstract available.
Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission.
Parma M, Viganò C, Fumagalli M, Colnaghi F, Colombo A, Mottadelli F, Rossi V, Elli E, Terruzzi E, Belotti A, Cazzaniga G, Pogliani EM, Pioltelli P. Parma M, et al. Among authors: pogliani em. Mediterr J Hematol Infect Dis. 2015 Jun 1;7(1):e2015041. doi: 10.4084/MJHID.2015.041. eCollection 2015. Mediterr J Hematol Infect Dis. 2015. PMID: 26075048 Free PMC article.
Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.
Introna M, Lucchini G, Dander E, Galimberti S, Rovelli A, Balduzzi A, Longoni D, Pavan F, Masciocchi F, Algarotti A, Micò C, Grassi A, Deola S, Cavattoni I, Gaipa G, Belotti D, Perseghin P, Parma M, Pogliani E, Golay J, Pedrini O, Capelli C, Cortelazzo S, D'Amico G, Biondi A, Rambaldi A, Biagi E. Introna M, et al. Biol Blood Marrow Transplant. 2014 Mar;20(3):375-81. doi: 10.1016/j.bbmt.2013.11.033. Epub 2013 Dec 7. Biol Blood Marrow Transplant. 2014. PMID: 24321746 Free article. Clinical Trial.
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
Larocca A, Piaggio G, Podestà M, Pitto A, Bruno B, Di Grazia C, Gualandi F, Occhini D, Raiola AM, Dominietto A, Bregante S, Lamparelli T, Tedone E, Oneto R, Frassoni F, Van Lint MT, Pogliani E, Bacigalupo A. Larocca A, et al. Haematologica. 2006 Jul;91(7):935-40. Haematologica. 2006. PMID: 16818281 Clinical Trial.
199 results